4/A
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040273
Options or other derivatives
- Chief Development Officer acquired 137,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · Chief Development Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 1 in the form Stock Option (right to buy) | +137,500 | 137,500 | D |
Loading xslF345X03/doc4a.xml…